Literature DB >> 22266433

Comparison of the efficacy of prednisolone versus prednisolone and acyclovir in the treatment of Bell`s palsy.

Alijan A Ahangar1, Seydreza Hosseini, Roshanak Saghebi.   

Abstract

OBJECTIVE: To compare the efficacy of 2 regimens of prednisolone versus prednisolone and acyclovir in the treatment of Bell`s palsy.
METHODS: A retrospective study was performed on 496 Bell`s palsy patients attending Yahyanejad Hospital, Babol, Iran from 1995 to 2004, divided in 2 groups. The first group was treated with regimen one (oral prednisolone), and the second group was treated with regimen 2 (oral prednisolone plus oral acyclovir) for 2 weeks. All cases were followed for 6 months.
RESULTS: Two hundred and forty-eight cases (108 males, 140 females) were treated with regimen one, and 248 cases (113 males, 135 females), were treated with regimen 2. Both groups had a mean age of 20-39 years. At the end of therapy, the recovery rate with regimen 2 was 95.6% (237 patients), whereas regimen one showed a recovery rate of 91.2% (226 patients) (p=0.047).
CONCLUSION: This study showed acyclovir plus prednisolone to be more effective than prednisolone alone in the treatment of Bell`s palsy.

Entities:  

Year:  2006        PMID: 22266433

Source DB:  PubMed          Journal:  Neurosciences (Riyadh)        ISSN: 1319-6138            Impact factor:   0.906


  3 in total

1.  Antiviral treatment for Bell's palsy (idiopathic facial paralysis).

Authors:  Ildiko Gagyor; Vishnu B Madhok; Fergus Daly; Frank Sullivan
Journal:  Cochrane Database Syst Rev       Date:  2019-09-05

Review 2.  The benefits of steroids versus steroids plus antivirals for treatment of Bell's palsy: a meta-analysis.

Authors:  Eudocia C Quant; Shafali S Jeste; Rajeev H Muni; Alison V Cape; Manveen K Bhussar; Anton Y Peleg
Journal:  BMJ       Date:  2009-09-07

3.  Comparison of the Efficacy of Combination Therapy of Prednisolone - Acyclovir with Prednisolone Alone in Bell's Palsy.

Authors:  Ali Khajeh; Afshin Fayyazi; Gholamreza Soleimani; Ghasem Miri-Aliabad; Sara Shaykh Veisi; Behrouz Khajeh
Journal:  Iran J Child Neurol       Date:  2015
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.